NCT04836156 2022-04-06Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer PatientsPeking University People's HospitalPhase 1/2 Recruiting46 enrolled